AR1004

N/A

Report date: 2024/11/21 10:21:20

Base Information

Drug NameAR1004
Drug Alias NameAR-1004AR1004
ClassificationNatural product/Extract
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsCognitive Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAribio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAribio Co Ltd
Inactive CompaniesN/A
Active IndicationsCognitive Dysfunction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A